Central Laboratory

Central Laboratory designates a specialised facility responsible for performing standardised laboratory testing for clinical trials across multiple sites, ensuring consistent sample handling, validated methodologies, and harmonised result reporting. Central labs typically manage sample logistics, chain of custody, processing, storage, and analysis for key trial endpoints such as clinical chemistry, haematology, immunogenicity, and biomarker measurements. This approach reduces variability compared to local site testing and strengthens data reliability for regulatory evaluation.

The biopharmaceutical industry increasingly relies on central laboratories to support global trials requiring consistent analytical outputs across regions, patient populations, and study phases. Central lab services include kit distribution, sample collection instructions, temperature-controlled transport, and secure reporting platforms enabling sponsors to monitor trends and outliers quickly. Quality systems include method validation, proficiency testing, equipment qualification, and strict documentation practices supporting audit readiness. Central labs also support specialised testing such as flow cytometry, pharmacodynamic biomarkers, and genomic assays used in precision medicine programmes. As trial complexity grows and biomarker-driven development becomes standard, central laboratories remain essential partners ensuring data comparability, regulatory confidence, and high-quality clinical evidence generation.